Summary:
In this research study, doctors want to test the safety and effectiveness of the study drug for Migraines.
Length of study: up to 36 weeks
Number of office visits: up to 13 visits
Criteria:This study is only available if the following apply to the potential participant:
- 18 years and older
- Is in stable medical health
- Migraine attacks on average, lasting 4-72 hours, if untreated
- Reads and understands English
Qualified Participants May Receive:
At no cost, qualified participants will receive:
- Study-related evaluation
- Study-related diagnostic and laboratory evaluations
- Investigational drug
- Reimbursement for time and travel for participant